Journal of the Neurological Sciences

Papers
(The H4-Index of Journal of the Neurological Sciences is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Central nervous system manifestations of COVID-19: A systematic review516
Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis322
Neurotropism of SARS-CoV 2: Mechanisms and manifestations170
The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries169
Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom169
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review157
Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic140
Neurological manifestations and COVID-19: Experiences from a tertiary care center at the Frontline136
COVID-19 related neuroimaging findings: A signal of thromboembolic complications and a strong prognostic marker of poor patient outcome133
A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications127
Cerebrospinal fluid in COVID-19: A systematic review of the literature125
Cerebrospinal fluid findings in COVID-19 patients with neurological symptoms119
Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic97
Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community92
Role of mitochondrial dysfunction, oxidative stress and autophagy in progression of Alzheimer's disease90
Posterior reversible encephalopathy syndrome in patients with COVID-1973
Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors72
COVID-19-associated mild encephalitis/encephalopathy with a reversible splenial lesion68
Time to diagnosis and factors affecting diagnostic delay in amyotrophic lateral sclerosis68
Teleneurology during the COVID-19 pandemic: A step forward in modernizing medical care67
Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-1966
Anosmia is associated with lower in-hospital mortality in COVID-1966
Correlations between COVID-19 and burden of dementia: An ecological study and review of literature64
Powered Air Purifying Respirator (PAPR) restores the N95 face mask induced cerebral hemodynamic alterations among Healthcare Workers during COVID-19 Outbreak62
Neurological involvement associated with COVID-19 infection in children61
Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series61
Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report60
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series59
COVID-19 in multiple sclerosis patients and risk factors for severe infection59
Myasthenic crisis in COVID-1958
Neurology of COVID-19 in Singapore57
Clinical uses of cannabis and cannabinoids in the United States56
Transcranial magnetic stimulation, deep brain stimulation, and other forms of neuromodulation for substance use disorders: Review of modalities and implications for treatment56
Has COVID-19 played an unexpected “stroke” on the chain of survival?55
The discerning eye of computer vision: Can it measure Parkinson's finger tap bradykinesia?53
Venous cerebral thrombosis in COVID-19 patient52
Susceptibility-weighted imaging reveals cerebral microvascular injury in severe COVID-1950
Metabolic stroke or stroke-like lesion: Peculiarities of a phenomenon49
A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses49
Wernicke-Korsakoff syndrome despite no alcohol abuse: A summary of systematic reports48
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose47
Revisiting the role of brain and peripheral Aβ in the pathogenesis of Alzheimer's disease46
Ketamine and nitrous oxide: The evolution of NMDA receptor antagonists as antidepressant agents44
The association of SARS-CoV-2 infection and acute disseminated encephalomyelitis without prominent clinical pulmonary symptoms44
0.031838893890381